Oguzhan Atay Sells 32,500 Shares of Billiontoone (NASDAQ:BLLN) Stock

Billiontoone, Inc. (NASDAQ:BLLN) CEO Oguzhan Atay sold 32,500 shares of the company’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $136.95, for a total transaction of $4,450,875.00. Following the completion of the transaction, the chief executive officer owned 20,000 shares in the company, valued at approximately $2,739,000. This represents a 61.90% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oguzhan Atay also recently made the following trade(s):

• On Monday, August 3rd, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The stock was sold at an average price of $137.37, for a total transaction of $1,717,125.00.
• On Thursday, July 9th, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The shares were sold at an average price of $126.10, for a total value of $1,576,250.00.
• On Monday, July 6th, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The shares were sold at an average price of $122.05, for a total value of $1,525,625.00.
• On Monday, July 6th, Oguzhan Atay sold 26,250 shares of Billiontoone stock. The stock was sold at an average price of $122.05, for a total value of $3,203,812.50.
• On Monday, June 8th, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The shares were sold at an average price of $98.22, for a total transaction of $1,227,750.00.
• On Monday, June 8th, Oguzhan Atay sold 26,250 shares of Billiontoone stock. The shares were sold at an average price of $97.66, for a total transaction of $2,563,575.00.

Billiontoone Price Performance

NASDAQ:BLLN traded up $7.72 during trading hours on Wednesday, reaching $149.97. The company’s stock had a trading volume of 906,494 shares, compared to its average volume of 626,551. Billiontoone, Inc. has a one year low of $61.96 and a one year high of $150.44. The business’s 50-day moving average is $116.73 and its 200-day moving average is $94.26. The company has a current ratio of 10.92, a quick ratio of 10.58 and a debt-to-equity ratio of 0.18.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.15. The company had revenue of $109.45 million during the quarter. Research analysts anticipate that Billiontoone, Inc. will post 0.92 EPS for the current year.

Institutional Trading of Billiontoone

Large investors have recently bought and sold shares of the stock. Adams Street Partners LLC acquired a new stake in shares of Billiontoone in the 4th quarter valued at $140,063,000. Baillie Gifford & Co. acquired a new stake in shares of Billiontoone during the fourth quarter worth approximately $103,786,000. Price T Rowe Associates Inc. MD acquired a new position in shares of Billiontoone in the 4th quarter worth approximately $39,717,000. JPMorgan Chase & Co. acquired a new stake in Billiontoone during the 4th quarter valued at $32,078,000. Finally, Wasatch Advisors LP acquired a new position in Billiontoone in the first quarter worth $29,179,000.

Analyst Ratings Changes

Several research firms recently weighed in on BLLN. BTIG Research cut their price objective on Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. JPMorgan Chase & Co. increased their price target on shares of Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Guggenheim started coverage on shares of Billiontoone in a research note on Monday, June 29th. They issued a “buy” rating and a $125.00 target price for the company. Finally, Weiss Ratings raised Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, June 23rd. Six equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $126.00.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.